Jump to navigation
The mifepristone-misoprostol regimen for early medical abortion
Providers, pills and power: The US mifepristone abortion trials and caregivers' interpretation of clinical power dynamics
Mifepristone abortion outside the urban research hospital setting in India
Can women in less-developed countries use a simplified medical abortion regimen?
Women's willingness to participate in microbicide trials in northern Thailand
Sexuality in the Middle East: Conference report
Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion
Accuracy of assessment of pregnancy duration by women seeking early abortions
Misoprostol alone: a new method of medical abortion?
Is medical abortion acceptable to all American women?: The impact of sociodemographic characteristics on the acceptability of mifepristone-misoprostol abortion